SecBot SecBot
Insider Cluster (2 insiders) ·Filed Sep 14, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.4M total
Actionable Insight • Neutral

The insider sales are routine profit-taking following deep-in-the-money option exercises. At 0.015% of market cap, this cluster carries no bearish signal. Monitor for any 10b5-1 plan adoption or further acceleration of sales, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$204.86
T+0 close · Sep 14, 2026 · via day close
Latest settled
−8.02%
T+20 · $188.44 · next T+60 in 22d
Vs SPY
−10.74%
α at T+20
Latest observation
−10.41%
T+42 · FF3 residual α
  1. T+0 · Sep 15 $204.86entry
  2. T+1 · 2mo ago −4.36%α −3.92% · $195.92
  3. T+5 · 8w ago −5.86%α −7.98% · $192.86
  4. T+20 · 5w ago −8.02%α −10.74% · $188.44
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Revolution Medicines executed a cluster of open-market sales totaling ~$6.5M over three days, with the bulk from C-suite executive Anthony Mancini ($3.15M) and director Lorence Kim ($3.59M). The sales follow option exercises by Mancini at $33.62/share, locking in massive gains at current ~$205 prices. At a $43.7B market cap, the total represents ~0.015%, well below the 0.1% materiality threshold, making this a routine liquidity event rather than an informed bearish signal. The cluster is amplified by the cross-filing insider-trades context, but the proportionality check overrides: the dollar amount is trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$6.5M
Insiders
2

Key Facts

  • Anthony Mancini (C-suite) sold 15,448 shares for ~$3.15M on Sep 10 after exercising options at $33.62/share
  • Lorence Kim (Director) sold 17,090 shares for ~$3.59M on Sep 8
  • Total open-market sales: ~$6.5M, representing ~0.015% of $43.7B market cap
  • Mancini also exercised 9,363 shares at $0 (non-cash) on Sep 10
  • No open-market purchases in the cluster, net direction is selling

Financial Impact

~$6.5M in insider sales, ~0.015% of market cap, trivial

dilution

Risk Factors

  • Insider selling could accelerate if the stock continues to rally
  • Option exercises followed by sales may signal insiders view current valuation as full

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (28 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1789425868525

US Market Status

Market Closed · Opens Wed (10h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026